HUL-owned Minimalist nears Rs 700 crore FY26 income, posts Rs 25.9 crore profit
Skincare brand Minimalist grew FY26 revenue from operations 36% to Rs 690.2 crore, with total income at Rs 697.4 crore. EBITDA more than doubled to Rs 40.2 crore despite a 55% rise in advertising and promotion spend to Rs 235 crore.
What happened
HUL-owned skincare D2C brand Minimalist grew FY26 operating revenue 36% to Rs 690.2 crore and posted Rs 25.9 crore PAT. EBITDA more than doubled to Rs 40.2
Key facts
- FY26 revenue from operations: Rs 690.2 crore
- FY26 total income: Rs 697.4 crore
- FY26 PAT: Rs 25.9 crore
- FY26 EBITDA: Rs 40.2 crore
- FY26 EBITDA margin: 5.82%
- FY26 advertising and promotion expense: Rs 235 crore
- HUL acquired 90.5% stake for Rs 2,955 crore in January 2025
Why this matters
Minimalist’s ability to sustain rapid growth and improve profitability under HUL strengthens the strategic case for acquiring differentiated, high-loyalty digital-native beauty brands with room for omnichannel scale.
What to watch
- Whether advertising spend growth moderates below revenue growth while revenue remains above 25%.
- EBITDA margin progression from the current roughly 5.8% of revenue toward high-single digits.
- Offline distribution expansion and evidence of sales contribution from general trade, modern trade, and pharmacies.
- Repeat-purchase rates, customer acquisition costs, and the share of revenue from owned versus paid digital channels.
- Competitive response from Indian and multinational skincare brands, especially discounting and ingredient-led product launches.
- Any deeper operational integration with HUL, including manufacturing, distribution, procurement, or portfolio changes.
- Increase offline and omnichannel reach through HUL-linked general trade, modern trade, and pharmacy distribution.
- Sustain high digital, influencer, and performance-marketing investment while shifting measurement toward repeat purchase and customer lifetime value.
- Expand high-margin skincare routines and selective adjacent categories, using hero ingredients and clinical-efficacy claims to defend premium pricing.
- Use HUL scale for sourcing, manufacturing, and logistics to improve gross margin and reduce delivery costs.
- Prioritize repeat-led growth, subscriptions, bundles, and CRM programs to reduce dependence on paid customer acquisition.
Also reported by
- Entrackr · Newsletter — Same time